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Background: The primary site of action of pregabalin, i.e. the α-2-δ subunit of the voltage-dependent calcium 
channel, is located at the dorsal root ganglion and dorsal horn of the spinal cord. Therefore, the epidural admini-
stration of pregabalin could have advantages over oral administration. However, the possibility of its neurotoxicity 
should be excluded before any attempt at epidural administration. We evaluated the neuronal safety of epidurally-
administered pregabalin by observing the sensory/motor changes and examining the histopathology of spinal cord 
in rats.
Methods: Sixty rats of 180-230 g were divided into three groups; 3 mg of pregabalin dissolved in 0.3 ml saline (group 
P, n = 20), 0.3 ml 40% alcohol (group A, n = 20), or 0.3 ml normal saline (group N, n = 20) was administered epidurally 
to the rats in each group. Pinch-toe test, motor function evaluation, and histopathologic examination of vacuolation, 
chromatolysis, meningeal inflammation, and neuritis were performed at the 1st, 3rd, 7th, and 21st day after each 
epidural administration.
Results: All rats enrolled in group P, like those in group N, showed neither sensory/motor dysfunction nor any 
histopathological abnormality over the 3-week observation period. In contrast, in group A, 80% of the rats showed 
abnormal response to the pinch-toe test and all rats showed decreased motor function during the entire evaluation 
period. In addition, all histopathologic findings of neurotoxicity were observed exclusively in group A. 
Conclusions: The epidurally administered pregabalin (about 15 mg/kg) did not cause any neurotoxic evidence, in 
terms of both sensory/motor function evaluation and histopathological examination in rats. (Korean J Anesthesiol 
2012; 62: 57-65)
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Introduction
Pregabalin (S-3-aminomethyl-5-methylhexanoic acid, 
LyricaⓇ, Pfizer, NY) is used for ameliorating either neuropathic 
or inflammatory pain [1-3]. Its analgesic effects act through 
the α-2-δ subunit of high voltage-activated N-type calcium 
channel, which is distributed primarily in the dorsal horn of 
the spinal cord and the presynaptic neuron of the dorsal root 
ganglion [4-7]. It has been shown that, when administered 
epidurally, ziconotide (i.e. one of calcium channel blockers) 
had better analgesic effects, reduced narcotic dose, and 
improved quality-of-life [4-8]. In addition, in animal studies, 
neuraxial administration of gabapentin was therapeutically 
effective, while reducing the dose, in comparison with 
other administration routes [5,9-12]. Based on these results, 
epidurally-administered pregabalin could affect either the 
dorsal horn or the dorsal root ganglion directly and rapidly, and 
by doing so might augment efficacy, reduce the dosage, and 
minimize side effects. 
Although oral pregabalin is used safely, direct intrathecal or 
epidural administration causes the direct contact of the nerve 
with drugs; the possibility of other unknown side-effects should 
be kept in mind, if administration route is changed [13,14]. 
With regard to this concern, Hassenbusch et al. [14] suggested 
the minimal standard that should be met prior to clinical 
uses. This standard recommends that in preclinical studies on 
the neuraxial administration of drugs, experiments on both 
neurotoxicity and side effects are ‘essential’, whereas other 
experiments, such as action mechanisms, pharmacodynamics 
or effectiveness, are ‘recommended’. If neuraxial pregabalin 
induces neurotoxicity by direct contact with the nerves, it could 
never be used in clinical practice, regardless of its effectiveness. 
Therefore, pertinent neurological safety must be provided in 
advance.
The purpose of this study was to provide the neurological 
safety of the epidural administration of pregabalin and to 
establish the basis for further animal and clinical studies; 
accordingly, pregabalin was administered to the epidural 
space of rats and the neurotoxicity elicited via this route was 
evaluated by both behavior observation and histopathological 
examination.
Materials and Methods
The experimental protocol was approved by the Institutional 
Animal Care and Use Committee in the Clinical Research Institute 
of our university hospital.
Sixty male Sprague-Dawley rats of 180-230 g were used. 
Prior to the study, all rats had free access to food and water and 
were individually housed, under 12-h light/dark cycle, for 1 
week. 
Pregabalin was provided by the manufacturer (Pfizer, NY) 
as white crystalline powder without any additives, and epidural 
catheters were prepared by cutting polyethylene catheters, 
which had an outer diameter of 0.61 mm (PE-10: Natsume, 
Japan) and approximately 15 cm in length, with knotting in the 
3 cm area. 
For epidural catheterization, each rat was anesthetized using 
spontaneous inhalation of 2-3% sevoflurane in oxygen, through 
a loose-fitting facial mask. After depilation and disinfection of the 
back area, epidural catheterization was performed according to 
the previously used technique for small animals [15-18], with 
some modification; thus, a 2-3 cm midline incision was made 
at the L5-L6 intervertebral space for exposure of the ligamentum 
flavum, and a small hole was made with a micro-scissor at 
the center of the ligamentum flavum. The prepared epidural 
catheter was inserted through the hole and gently advanced 
about 3 cm cephalad, for the catheter tip to be placed in the L1 
region. The catheter entry site was sealed with α-cyanoacetylate 
(Aron-AlphaⓇ, Toagosei, Japan), and the wound was sutured 
layer by layer, after irrigation with saline. To confirm correct 
epidural placement of the catheter, 0.15 ml of 2% lidocaine was 
injected through the catheter after recovery from anesthesia; 
if the rat showed transient hind-limb paralysis, the catheter 
was regarded to be positioned in the epidural space. If sudden 
respiratory arrest was observed during lidocaine injection, the 
test solution was regarded to be injected either intrathecally 
or intravenously, and such cases were excluded from the 
study. In addition, the rats with aspiration of either blood or 
cerebrospinal fluid through the catheter, with leakage of drugs 
at the insertion area, or without any paralytic symptom in the 
hind limbs after lidocaine injection, were also excluded. After 
confirming correct epidural catheter placement, we observed 
the gait, spinal deformity, and behavioral abnormalities for 3 
days. If the rats showed no abnormal findings during the 3-day 
observation period, they were included in this study.
The rats were divided into 3 groups, according to the injected 
solution; group A was injected with 40% alcohol, group N was 
injected with saline, and group P was injected with 0.3 mg of 
pregabalin. The total injected volume was 0.3 ml, excluding 
the volume within the catheter. The study drugs were injected 
slowly under general anesthesia. After injection, the rats were 
individually housed under a 12-h light/dark cycle. 
Acute toxicity was evaluated on the 1st and 3rd days, and 
chronic toxicity on the 7th and 21st days after epidural injection 
of the study drugs. One examiner, who was unaware of the 
study groups, observed the motor and sensory deficits. To 
evaluate both motor and sensory deficits, the pinch-toe test 
was performed by applying pain in the hind sole of rats and 
observing the responses to avoid it [18-20]; thus, the hind sole 
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was pinched with a pair of forceps (01-1155, Solco, Korea) 
for maximum 6 seconds and the test was repeated 3 times, at 
intervals of at least 5 minutes. Motor function was assessed 
using a previously devised scoring system [18,21]; grades were 
defined, as follows: grade 1 = normal gait, with no evidence 
of motor paresis; grade 2 = normal gait, with slight hind paw 
deformity, such as plantar flexion of toes; grade 3 = slight gait 
disturbance, with motor weakness and/or an inverted hind 
paw; and grade 4 = prominent limping gait, with a dropped hind 
paw. Animals scoring higher than grade 2 were considered to 
have motor deficit.
Following behavioral observation, spinal cords were har-
vested on days 1, 3, 7 and 21 after drug administration, from 
5 rats of each group, for histological tests. Under sevoflurane 
general anesthesia delivered via facemask, euthanasia and 
fixation were simultaneously induced by transcardial perfusion 
with 4% paraformaldehyde solution, mixed with 0.1 M 
phosphate buffer. Approximately 1 cm length of lumbar spinal 
cord (i.e. where the catheter tip was located) was harvested 
and fixed in 10% neutral formalin solution. According to 
conventional tissue sample preparation methods, the fixed 
tissues were made as paraffin blocks, and 4-5 μm thick 
sections were prepared for the slides. Primarily, Hematoxylin-
eosin staining was performed to assess general histopathologic 
findings; then, four neurotoxicity categories were assessed, as 
previously reported: ① vacuolization of the dorsal funiculus, 
② chromatolysis of the motor neuron in the ventral horn, ③ 
neuritis, and ④ meningeal inflammation [18,22-24]. Among 
them, the vacuolization of the dorsal funiculus was subdivided 
into 4 grades: grade 0 = no vacuole, grade 1 = vacuoles observed 
in less than 10% of the dorsal funiculus surface, grade 2 = 
vacuoles observed in 10-50% of the surface, and grade 3 
= vacuoles observed in more than 50% of the surface. For 
further evaluation of myelin injury, Luxol fast blue staining 
was added. Next, the neurofilament immunochemical staining 
was performed for in-depth assessment of the degree of axonal 
injury. One pathologist, who did not know the group allocation, 
performed all histological evaluation. 
Intergroup comparisons of the body weight were analyzed 
using one way ANOVA on ranks, followed by the Duncan test. In 
all groups, the Fisher’s exact test and Bonferroni correction were 
performed to analyze the impairment of motor and sensory 
function and the histological tests. For all statistical analyses, 
the SPSS software version 13.0 (SPSS, Chicago, IL) was used, 
and a P value < 0.05 was considered as statistically significant.
Results
At first, 71 animals were enrolled in total; however, 8 rats died 
due to sudden respiratory arrest after lidocaine injection and 3 
rats in group A expired before the completion of the study. Thus, 
our final data were obtained from 60 rats. 
Any rats did not show abnormal behavior, such as aggressi-
veness, severe crying, or excited behaviors, after the admini-
stration of the study drugs. 
At 21 days after drug injection, the rats in group A showed 
decreased mean body weight, compared to the other two groups 
(Table 1).
The rats in groups P and N showed normal avoiding 
responses for the pinch-toe test and motor function of grade 1 
at all observation periods. However, in group A, 75% rats on the 
day 1 and 80% rats on the day 21 showed either insufficient or 
Table 1. Changes in the Rat Body Weight after Epidural Drug Injection
Day after epidural 
drug injection
Baseline
(n = 20/group)
1st day
(n = 20/group)
3rd day
(n = 15/group)
7th day
(n = 10/group)
21st day
(n = 5/group)
Group N
Group P
Group A
199.4 ± 19.2
200.3 ± 17.3
198.2 ± 22.4
200.6 ± 22.9
205.3 ± 21.2
202.0 ± 24.0
227.5 ± 10.8
230.3 ± 15.7
207.4 ± 18.3
272.0 ± 7.3
277.2 ± 12.8
250.8 ± 14.3
432.0 ± 25.0
440.2 ± 21.0
345.0 ± 17.0*
Values are expressed as mean ± SD. Group N: epidural injection of 0.3 ml of normal saline, Group P: epidural injection of 3 mg/0.3 ml of 
pregabalin, and Group A: epidural injection of 0.3 ml of 40% alcohol. *P < 0.05: group A vs. group N and group P.
Table 2. Evaluation of the Pinch-toe Test at Each Observation Point, after the Epidural Drug Injection
Day after epidural  
drug injection
1st day
(n = 20/group)
3rd day
(n = 15/group)
7th day
(n = 10/group)
21st day
(n = 5/group)
Group N
Group P
Group A
0 (0)
0 (0)
15 (75)*
0 (0)
0 (0)
13 (87)*
0 (0)
0 (0)
9 (90)*
0 (0)
0 (0)
4 (80)*
Values are expressed as number (%) of rats, out of the total number, which showed abnormal response. Group N: epidural injection of 0.3 ml 
of normal saline, Group P: epidural injection of 3 mg/0.3 ml of pregabalin, and Group A: epidural injection of 0.3 ml of 40% alcohol. *P < 0.05: 
group A vs. group N and group P.
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no response for the pinch-toe test. In addition, at all observation 
times, all rats in group A showed gait abnormality and the hind 
limb deformity higher than grade 2 (Table 2 and 3)
The results of histological neurotoxicity assessed by light 
micro scope were, as follows; in the N and P groups, the 
structure was well maintained, and there was no region sugges-
ting neurotoxicity with chromatolysis of motor ganglions, 
vacuoli zation of the dorsal funiculus higher than grade 2, 
neuritis, or meningeal inflammation. In contrast, in group A, 
vacuoli zation was observed in all tissues (Table 4, Fig. 1 and 2). 
Neurofilament staining was performed for further evaluation 
of some tissues with equivocal vacuolization on the H&E stain; 
thus, in groups N and P, the axon injury was very scanty on the 
neurofilament staining. In contrast, significant degeneration 
and loss of axons was observed in the tissues of group A, with 
vacuolization of not only grade 2-3, but also grade 1 on the 
H&E stain (Fig. 3). In addition, both meningeal inflammation 
and neuritis were observed in tissues from the rats in group A, 
which was not detected in either group N or P (Fig. 4 and 5). 
Discussion
From our results, epidurally administered pregabalin did not 
cause any acute or chronic neurotoxicity in rats. 
Dose and volume are essential factors for adequacy of 
toxicity study. Considering an epidural dose of 1/10-1/30 of the 
oral dose, the maximal dose of epidural pregabalin in human is 
estimated at 20-60 mg. The applied dose in the present study 
could be regarded as the equivalent of 900 mg in a 60 kg adult; 
therefore, our study dose was 15-45 times higher than the 
dose expected to be used in clinical practice. In addition, the 
maximal dose of oral pregabalin previously used in rats was 30 
mg/kg [25-27]. From this, the epidural dose of pregabalin in 
the rat was estimated at 1-3 mg/kg. Taken together, the dose 
used in our experiment should be considered as sufficient for 
evaluation of neurotoxicity. In a previous study of epidural 
Table 3. Evaluation of the Motor Function at Each Observation Point, after Epidural Drug Injection
Day after epidural drug injection
1st day
(n = 20/group)
3rd day
(n = 15/group)
7th day
(n = 10/group)
21st day
(n = 5/group)
Group N
Group P
Group A
G1
G2-4
G1
G2-4
G1
G2-4
20 (100)
0 (0)
20 (100)
0 (0)
0 (0)
20 (100)*
15 (100)
0 (0)
15 (100)
0 (0)
0 (0)
15 (100)*
10 (100)
0 (0)
10 (100)
0 (0)
0 (0)
10 (100)*
5 (100)
0 (0)
5 (100)
0 (0)
0 (0)
5 (100)*
Values are expressed as number (%) of rats out of total. Group N: epidural injection of 0.3 ml of normal saline, Group P: epidural injection of 3 
mg/0.3 ml of pregabalin, Group A: epidural injection of 0.3 ml of 40% alcohol. G: grade of motor function, G1: normal gait, with no evidence of 
motor paresis; G2: normal gait, with slight hind paw deformity; G3: slight gait disturbance, with motor weakness and/or an inverted hind paw, 
and G4: prominent limping gait, with a dropped hind paw. *P < 0.05: group A vs. group N and group P.
Table 4. Neuropathological Findings of Spinal Cord and Surrounding Tissues under Microscopic Examination, after the Epidural Injection of Test Drugs
Group  
Grade
1st day† (n = 5) 3rd day† (n = 5) 7th day† (n = 5) 21st day† (n = 5)
0 I II III 0 I II III 0 I II III 0 I II III
Vacuolation
Chromatolysis
Neuritis
Meningeal inflammation
N
P
A*
N
P
A
N
P
A
N
P
A
5
5
0
0
0
3
0
0
2
0
0
0
5
5
0
0
0
0
0
0
2
0
0
3
5
4
0
0
1
0
0
0
2
0
0
3
4
4
0
1
1
0
0
0
1
0
0
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
  3*
0
0
  2*
0
0
0
0
0
  3*
0
0
  3*
Values are expressed as number of positive rats out of the total. Group N: epidural injection of 0.3 ml of normal saline, Group P: epidural 
injection of 3 mg/0.3 ml of pregabalin, and Group A: epidural injection of 0.3 ml of 40% alcohol. The grade of the vacuolation was assessed with 
a four-point scale, 0: no vacuolation, I: < 10% area, II: 10-50% area, and III: > 50 % area of the dorsal funiculus vacuolated. *P < 0.05: group A 
vs. group N and group P. †Days after epidural drug injection. 
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Fig. 1. The degree of vacuolization in the dorsal funiculus. (A, B) Epidural injection of 0.3 ml of normal saline, (C, D) Epidural injection of 3 
mg/0.3 ml of pregabalin, and (E, F) Epidural injection of 0.3 ml of 40% alcohol. The pictures of (A-C) and (D) show no (A, C) or only mild (B, D) 
vacuolization. In contrast, the pictures of (E) and (F) show moderate and severe vacuolization, respectively. Hematoxylin and eosin stain.
Fig. 2. The degree of myelin loss in the dorsal funiculus. (A, B) Epidural injection of 0.3 ml of normal saline, (C, D) Epidural injection of 3 mg/0.3 
ml of pregabalin, and (E, F) Epidural injection of 0.3 ml of 40% alcohol. The pictures of (A-C) and (D) show normal morphology of myelin. In 
contrast, the pictures of (E) and (F) show severe myelin loss, presented as vacuolization on the previous hematoxylin-eosin stain. Luxol fast blue 
stain.
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Fig. 3. The degree of axonal degeneration in the dorsal funiculus. (A, B) Epidural injection of 0.3 ml of normal saline, (C, D) Epidural injection 
of 3 mg/0.3 ml of pregabalin, and (E, F) Epidural injection of 0.3 ml of 40% alcohol. The pictures of (A-C) and (D) show no significant axonal 
degeneration, although (B) and (D) showed mild vacuolization on the hematoxylin-eosin stain. In contrast, (E) and (F) show significant axonal 
degeneration, with moderate and severe vacuolization seen, respectively, on the hematoxylin-eosin stain. Immunohistochemical stain with 
neurofilament antibody.
Fig. 4. The degree of meningeal inflammation. (A, B) Epidural injection of 0.3 ml of normal saline, (C, D) Epidural injection of 3 mg/0.3 ml of 
pregabalin, and (E, F) Epidural injection of 0.3 ml of 40% alcohol. The meninges of (A-D) are thin and show no infiltration of inflammatory cells. 
In contrast, the meninges of (E) and (F) are thickened and show heavy infiltration of inflammatory cells, such as neutrophils (black arrow). 
Hematoxylin and eosin stain.
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gabapentin, the study dose was calculated from the intrathecal 
dose [18]. However, such data was unavailable in the case of 
pregabalin. In addition, the dose used in our study did not 
induce any systemic toxic symptoms. Therefore, we consider 
that additional dose adjustments of toxicity study would not be 
required. 
The volume of drug should be also considered, because it is 
also essential in toxicity study. It has been shown that epidural 
administration of 0.1 ml in rats is equivalent to administration of 
10-15 ml in humans [15]. Similarly, a volume of 0.3 ml contrast 
medium was known to spread throughout the 10-11 segments 
of vertebra in rats; most other drugs would spread more widely, 
because they have lower viscosity than the contrast media [18]. 
In our study, the catheter tip was placed in the L1 area and 0.3 
ml pregabalin was administered; thus, pregabalin could spread 
at least from the 9th thoracic vertebra to the 6th lumbar vertebra 
and it was sufficient to examine the motor and sensory changes 
in the hind limbs innervated by the 3rd to the 6th lumbar nerve 
roots. Additionally, it was suitable for obtaining spinal cord 
tissue from the L1 area, where the tip of the catheter was placed. 
The pinch-toe test is a method to evaluate either the 
paralysis of hind limbs or the deterioration of nociperception 
in rodent study. The grade system used in our study was also 
used in the neurotoxicity study of Choi et al. [18], as well as 
in the study from Bajrovic and Sketelj [20]. In addition, motor 
function was assessed by gait patterns and the deformity of 
hind limbs as previously described [21], but only grade 1 was 
con sidered as normal, in order to increase test sensitivity. 
Moreover, histological tests are essential, because most organs 
have sufficient ability to overcome the damaged function; 
consequently, observing only the behavioral pattern may 
underestimate neurotoxicity [28]. Histological findings 
associated with neurotoxicity could be classified as nerve 
damage, gliosis, loss of myelin, and inflammation in the 
adjacent tissues [29]. Therefore, in our study, chromatolysis 
of motor nerve ganglions, vacuolization of the dorsal 
funiculus, and neuritis associated with abnormal infiltration 
of lymphocytes were assessed to determine the nerve 
damage, myelin loss, and inflammation in the adjacent tissue, 
respectively. Group A exhibited all neurotoxicity findings. 
Although grade 1 vacuolization was observed in some cases of 
the P group on the days 7 and 21 after drug administration, this 
finding was also detected in group N, which was the negative 
control group. Furthermore, on the neurofilament staining, 
the tissues with minimal vacuolization in groups P and N were 
similar to the normal tissues, but clearly distinguishable from 
group A. Therefore, we conclude that epidural administration 
of pregabalin did not induce nerve damage, as assessed both 
functionally and histologically. 
Neuraxial administration includes subarachnoid and 
epidural administration. Epidural administration has the 
advantage of acting on nerve ganglions passing through 
Fig. 5. Neuritis in the spinal neurons. (A, B) Epidural injection of 0.3 ml of normal saline, (C, D) Epidural injection of 3 mg/0.3 ml of pregabalin, 
and (E, F) Epidural injection of 0.3 ml of 40% alcohol. In (A-D) there is no infiltration of inflammatory cells. In contrast, (E and F) show heavy 
infiltration of inflammatory cells, such as neurophils (black arrow). Hematoxylin and eosin stain.
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the epidural space, hence the effect of the peripheral nerve 
block could be achieved simultaneously [8]. Therefore, it is a 
favored method in clinical practice. In the present study, the 
neurological safety of epidurally administered pregabalin was 
proven. However, it is controversial to extrapolate the results 
to the safety of the intrathecal administration. Moreover, in 
this study, a high dose of pregabalin was administered as a 
single dose, and thus it may not concur to the results of chronic 
epidural injection. 
Prior to clinical application, assessment of neurotoxicity 
of drugs in animal species which are closer to humans is 
recommended [13,14]. Therefore, based on our study, additional 
studies should be conducted to confirm safety at the standard 
at which it could be directly applied in clinical practice.
In conclusion, when pregabalin at 15 mg/kg dose was 
administered to the epidural space of rats, we found no neuro-
toxic effects, assessed by both behavior observation and patho-
histological examination. If the results of the neurological safety 
of pregabalin are proven in other animal species in the future, 
the epidural administration of pregabalin may improve treat-
ment effectiveness.
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